These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

249 related items for PubMed ID: 15854553

  • 21. A novel oncolytic adenovirus targeting to telomerase activity in tumor cells with potent.
    Zou W, Luo C, Zhang Z, Liu J, Gu J, Pei Z, Qian C, Liu X.
    Oncogene; 2004 Jan 15; 23(2):457-64. PubMed ID: 14724574
    [Abstract] [Full Text] [Related]

  • 22. E1A, E1B double-restricted replicative adenovirus at low dose greatly augments tumor-specific suicide gene therapy for gallbladder cancer.
    Fukuda K, Abei M, Ugai H, Kawashima R, Seo E, Wakayama M, Murata T, Endo S, Hamada H, Hyodo I, Yokoyama KK.
    Cancer Gene Ther; 2009 Feb 15; 16(2):126-36. PubMed ID: 18818710
    [Abstract] [Full Text] [Related]

  • 23. Conditionally replicative adenovirus vector carrying TRAIL gene for enhanced oncolysis of human hepatocellular carcinoma.
    Ye X, Lu Q, Zhao Y, Ren Z, Ren XW, Qiu QH, Tong Y, Liang M, Hu F, Chen HZ.
    Int J Mol Med; 2005 Dec 15; 16(6):1179-84. PubMed ID: 16273304
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. A novel A33 promoter-based conditionally replicative adenovirus suppresses tumor growth and eradicates hepatic metastases in human colon cancer models.
    Cafferata EG, Macció DR, Lopez MV, Viale DL, Carbone C, Mazzolini G, Podhajcer OL.
    Clin Cancer Res; 2009 May 01; 15(9):3037-49. PubMed ID: 19336523
    [Abstract] [Full Text] [Related]

  • 28. Adenovirus-mediated HSV-TK gene therapy using the human telomerase promoter induced apoptosis of small cell lung cancer cell line.
    Song JS, Kim HP.
    Oncol Rep; 2004 Aug 01; 12(2):443-7. PubMed ID: 15254714
    [Abstract] [Full Text] [Related]

  • 29. Potent antitumoral efficacy of a novel replicative adenovirus CNHK300 targeting telomerase-positive cancer cells.
    Su CQ, Sham J, Xue HB, Wang XH, Chua D, Cui ZF, Peng LH, Li LF, Jiang LH, Wu MC, Qian QJ.
    J Cancer Res Clin Oncol; 2004 Oct 01; 130(10):591-603. PubMed ID: 15243805
    [Abstract] [Full Text] [Related]

  • 30. A fiber-modified, secretory leukoprotease inhibitor promoter-based conditionally replicating adenovirus for treatment of ovarian cancer.
    Rein DT, Breidenbach M, Kirby TO, Han T, Siegal GP, Bauerschmitz GJ, Wang M, Nettelbeck DM, Tsuruta Y, Yamamoto M, Dall P, Hemminki A, Curiel DT.
    Clin Cancer Res; 2005 Feb 01; 11(3):1327-35. PubMed ID: 15709205
    [Abstract] [Full Text] [Related]

  • 31. Midkine promoter-driven suicide gene expression and -mediated adenovirus replication produced cytotoxic effects to immortalised and tumour cells.
    Yu L, Hamada K, Namba M, Kadomatsu K, Muramatsu T, Matsubara S, Tagawa M.
    Eur J Cancer; 2004 Jul 01; 40(11):1787-94. PubMed ID: 15251170
    [Abstract] [Full Text] [Related]

  • 32. Replicating adenoviral vector-mediated transfer of a heat-inducible double suicide gene for gene therapy.
    Lee YJ, Galoforo SS, Battle P, Lee H, Corry PM, Jessup JM.
    Cancer Gene Ther; 2001 Jun 01; 8(6):397-404. PubMed ID: 11498759
    [Abstract] [Full Text] [Related]

  • 33. Replication of an adenoviral vector controlled by the human telomerase reverse transcriptase promoter causes tumor-selective tumor lysis.
    Lanson NA, Friedlander PL, Schwarzenberger P, Kolls JK, Wang G.
    Cancer Res; 2003 Nov 15; 63(22):7936-41. PubMed ID: 14633724
    [Abstract] [Full Text] [Related]

  • 34. [Tumor-selective replication, cytotoxicity and GM-CSF production of oncolytic recombinant adenovirus in KH901 injection].
    Shen FB, Chang JH, Yang C, Li J, Guo Y, Yi B, Li HX, Ye XF, Wang L.
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Jan 15; 38(1):31-4. PubMed ID: 17294722
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Novel oncolytic adenoviruses targeted to melanoma: specific viral replication and cytolysis by expression of E1A mutants from the tyrosinase enhancer/promoter.
    Nettelbeck DM, Rivera AA, Balagué C, Alemany R, Curiel DT.
    Cancer Res; 2002 Aug 15; 62(16):4663-70. PubMed ID: 12183423
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. [Construction of a plasmid vector of fused protein genes driven by human insulin-like growth factor II P3 promoter].
    Zhou HK, Yang DH, Tang SH, Huang W, Lu XH.
    Zhonghua Yi Xue Za Zhi; 2006 Jan 10; 86(2):106-10. PubMed ID: 16620715
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.